CLINICAL_TRIALS
ClinicalTrials.gov record update
An Open-Label, 2-Part, Randomized, Crossover Study to Compare the Bioavailability of Intranasal Administration of 200 and 400 µg of OPTINOSE™ FLUTICASONE With 400 µg of Flonase® (Fluticasone Propionate) Nasal Spray (Part 1), and Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) (Current Investigation is Part 2 Only)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02266927
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:00.546613+00:00
- Published At
- 2016-02-03T00:00:00+00:00
- Record Updated At
- 2016-02-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Mild to Moderate Asthma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-02-03"- protocolSection.identificationModule.nctId
"NCT02266927"- protocolSection.identificationModule.officialTitle
"An Open-Label, 2-Part, Randomized, Crossover Study to Compare the Bioavailability of Intranasal Administration of 200 and 400 \u00b5g of OPTINOSE\u2122 FLUTICASONE With 400 \u00b5g of Flonase\u00ae (Fluticasone Propionate) Nasal Spray (Part 1), and Intranasal Administration of 200 and 400 \u00b5g or 400 \u00b5g Alone of OPTINOSE\u2122 FLUTICASONE With 440 \u00b5g of Flovent\u00ae HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) (Current Investigation is Part 2 Only)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.